Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026)

Hims & Hers Health (HIMS) reported Change in Acquisitions & Divestments of $93.3 million for Q1 2026, up 197.53% on a YoY basis from $31.3 million in Q1 2025, and down 14.21% sequentially from $108.7 million in Q4 2025.

Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $93.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 197.53% year-over-year to $93.3 million; the trailing twelve-month figure through Mar 2026 stood at $170.6 million (up 19.66% YoY), and the FY2025 full-year result was $108.7 million, down 47.98% from the prior year.
  • Change in Acquisitions & Divestments eased to $93.3 million in Q1 2026, from $108.7 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $208.2 million in Q4 2024 to a low of -$125.4 million in Q3 2024.
  • A 5-year average of $40.4 million and a median of $31.3 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
  • Across the five-year window, Change in Acquisitions & Divestments tumbled 14061.02% in 2024 and jumped 197.53% in 2026, its largest moves.
  • Tracing HIMS's Change in Acquisitions & Divestments over 5 years: stood at $59.5 million in 2022, then tumbled by 98.49% to $898000.0 in 2023, then jumped by 23086.53% to $208.2 million in 2024, then tumbled by 47.8% to $108.7 million in 2025, then slipped by 14.21% to $93.3 million in 2026.
  • Business Quant data shows HIMS's Change in Acquisitions & Divestments at $93.3 million in Q1 2026, $108.7 million in Q4 2025, and -$60.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 93.25 Mn
Mar 31, 2026 93.25 Mn
Dec 31, 2025 108.70 Mn
Dec 31, 2025 108.70 Mn
Sep 30, 2025 -60.57 Mn
Sep 30, 2025 -60.57 Mn
Jun 30, 2025 29.23 Mn
Jun 30, 2025 29.23 Mn
Mar 31, 2025 31.34 Mn
Mar 31, 2025 31.34 Mn
Dec 31, 2024 208.22 Mn
Dec 31, 2024 208.22 Mn
Sep 30, 2024 -125.37 Mn
Sep 30, 2024 -125.37 Mn
Jun 30, 2024 28.40 Mn
Jun 30, 2024 28.40 Mn
Mar 31, 2024 97.70 Mn
Mar 31, 2024 97.70 Mn
Sep 30, 2023 898,000.00
Sep 30, 2023 898,000.00